Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

513 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force "Dermatology for Cancer Patients" International Study.
Sollena P, Vasiliki N, Kotteas E, Stratigos AJ, Fattore D, Orlandi A, Mannino M, Di Pumpo M, Fida M, Starace M, Apalla Z, Romano MC, Riganti J, Segura S, Martinez AF, Fabbrocini G, Sibaud V, Peris K, On Behalf Of The Eadv Task Force Dermatology For Cancer Patients. Sollena P, et al. Among authors: orlandi a. Cancers (Basel). 2023 Jul 18;15(14):3658. doi: 10.3390/cancers15143658. Cancers (Basel). 2023. PMID: 37509319 Free PMC article.
Diagnosis and Treatment of Bone Metastases in Breast Cancer: Radiotherapy, Local Approach and Systemic Therapy in a Guide for Clinicians.
Marazzi F, Orlandi A, Manfrida S, Masiello V, Di Leone A, Massaccesi M, Moschella F, Franceschini G, Bria E, Gambacorta MA, Masetti R, Tortora G, Valentini V. Marazzi F, et al. Among authors: orlandi a. Cancers (Basel). 2020 Aug 24;12(9):2390. doi: 10.3390/cancers12092390. Cancers (Basel). 2020. PMID: 32846945 Free PMC article. Review.
Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors.
Sollena P, Nikolaou V, Soupos N, Kotteas E, Voudouri D, Stratigos AJ, Fattore D, Annunziata MC, Orlandi A, Di Nardo L, Apalla Z, Deilhes F, Romano MC, Fabbrocini G, Sibaud V, Peris K; European Network for Cutaneous ADverse event of Oncologic drugs (ENCADO) group. Sollena P, et al. Among authors: orlandi a. Breast Cancer Res Treat. 2021 Jan;185(1):247-253. doi: 10.1007/s10549-020-05914-w. Epub 2020 Sep 10. Breast Cancer Res Treat. 2021. PMID: 32914354
CDK4/6 Inhibitor Treatments in Patients with Hormone Receptor Positive, Her2 Negative Advanced Breast Cancer: Potential Molecular Mechanisms, Clinical Implications and Future Perspectives.
Roberto M, Astone A, Botticelli A, Carbognin L, Cassano A, D'Auria G, Fabbri A, Fabi A, Gamucci T, Krasniqi E, Minelli M, Orlandi A, Pantano F, Paris I, Pizzuti L, Portarena I, Salesi N, Scagnoli S, Scavina P, Tonini G, Vici P, Marchetti P. Roberto M, et al. Among authors: orlandi a. Cancers (Basel). 2021 Jan 18;13(2):332. doi: 10.3390/cancers13020332. Cancers (Basel). 2021. PMID: 33477469 Free PMC article. Review.
Clinical, Pathological and Prognostic Features of Rare BRAF Mutations in Metastatic Colorectal Cancer (mCRC): A Bi-Institutional Retrospective Analysis (REBUS Study).
Calegari MA, Salvatore L, Di Stefano B, Basso M, Orlandi A, Boccaccino A, Lombardo F, Auriemma A, Zurlo IV, Bensi M, Camarda F, Ribelli M, Vivolo R, Cocomazzi A, Pozzo C, Milella M, Martini M, Bria E, Tortora G. Calegari MA, et al. Among authors: orlandi a. Cancers (Basel). 2021 Apr 27;13(9):2098. doi: 10.3390/cancers13092098. Cancers (Basel). 2021. PMID: 33925278 Free PMC article.
Case report: Vitiligo-like toxicity due to ribociclib during first-line treatment of metastatic breast cancer: two cases of premature interruption of therapy and exceptional response.
Pasqualoni M, Orlandi A, Palazzo A, Garufi G, Cannizzaro MC, Pontolillo L, Pannunzio S, Cutigni C, Sollena P, Federico F, Bria E, Tortora G. Pasqualoni M, et al. Among authors: orlandi a. Front Oncol. 2023 Mar 9;13:1067264. doi: 10.3389/fonc.2023.1067264. eCollection 2023. Front Oncol. 2023. PMID: 36969030 Free PMC article.
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies.
Rachiglio AM, Forgione L, Pasquale R, Barone CA, Maiello E, Antonuzzo L, Cassata A, Tonini G, Bordonaro R, Rosati G, Zaniboni A, Lonardi S, Ferrari D, Frassineti GL, Tamberi S, Pisconti S, Di Fabio F, Roma C, Orlandi A, Latiano T, Damato A, Tortora G, Pinto C, Normanno N. Rachiglio AM, et al. Among authors: orlandi a. Cancers (Basel). 2022 Feb 18;14(4):1052. doi: 10.3390/cancers14041052. Cancers (Basel). 2022. PMID: 35205799 Free PMC article.
Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience.
Di Leone A, Franco A, Terribile DA, Magno S, Fabi A, Sanchez AM, D'Archi S, Scardina L, Natale M, Mason EJ, Murando F, Marazzi F, Orlandi A, Paris I, Visconti G, Palazzo A, Masiello V, Barone Adesi L, Salgarello M, Masetti R, Franceschini G. Di Leone A, et al. Among authors: orlandi a. Cancers (Basel). 2022 Mar 1;14(5):1275. doi: 10.3390/cancers14051275. Cancers (Basel). 2022. PMID: 35267583 Free PMC article.
513 results